Revance Therapeutics Inc (NASDAQ:RVNC)

30.60
Delayed Data
As of Apr 20
 -2.75 / -8.25%
Today’s Change
18.43
Today|||52-Week Range
37.45
-14.41%
Year-to-Date
No recent news for Revance Therapeutics Inc.

Today’s Trading

Previous close33.35
Today’s open33.20
Day’s range30.50 - 33.20
Volume441,532
Average volume (3 months)369,135
Market cap$1.2B
Data as of 4:00pm ET, 04/20/2018

Growth & Valuation

Earnings growth (last year)-26.10%
Earnings growth (this year)+8.70%
Earnings growth (next 5 years)--
Revenue growth (last year)-12.67%
P/E ratioNM
Price/Sales4,107.31
Price/Book4.45

Competitors

 Today’s
change
Today’s
% change
VNDAVanda Pharmaceutical...+0.10+0.68%
AMPHAmphastar Pharmaceut...-0.17-0.87%
INSMInsmed Inc+0.41+1.77%
ACRSAclaris Therapeutics...+0.13+0.74%
Data as of 4:00pm ET, 04/20/2018

Financials

Next reporting dateMay 16, 2018
EPS forecast (this quarter)-$0.85
Annual revenue (last year)$262.0K
Annual profit (last year)-$120.6M
Net profit margin-46,025.57%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
L. Daniel Browne
Chief Operating Officer
Abhay Joshi
Corporate headquarters
Newark, California

Forecasts